These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11309710)

  • 1. Cytokine immunotherapy during bacterial pneumonia: from benchtop to bedside.
    Moore TA; Standiford TJ
    Semin Respir Infect; 2001 Mar; 16(1):27-37. PubMed ID: 11309710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine treatment of bacterial pneumonia.
    Nelson S; Bagby GJ; Dale D
    Semin Respir Infect; 2001 Mar; 16(1):38-46. PubMed ID: 11309711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cytokines in bacterial pneumonia: an inflammatory balancing act.
    Moore TA; Standiford TJ
    Proc Assoc Am Physicians; 1998; 110(4):297-305. PubMed ID: 9686677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia.
    Shindo Y; Fuchs AG; Davis CG; Eitas T; Unsinger J; Burnham CD; Green JM; Morre M; Bochicchio GV; Hotchkiss RS
    J Leukoc Biol; 2017 Feb; 101(2):543-554. PubMed ID: 27630218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation--a new therapeutic target in pneumonia.
    Cazzola M; Matera MG; Pezzuto G
    Respiration; 2005; 72(2):117-26. PubMed ID: 15824518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic modulation of cytokines in chronic infectious diseases.
    Villar CC; Dongari-Bagtzoglou A
    Curr Pharm Des; 2006; 12(19):2329-48. PubMed ID: 16842182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic antibiotic treatment of nosocomial pneumonia.
    Unertl KE; Lenhart FP; Forst H; Peter K
    Intensive Care Med; 1992; 18 Suppl 1():S28-34. PubMed ID: 1640030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 and related pro-inflammatory cytokines in the treatment of bacterial infections in neutropenic and non-neutropenic animals.
    van der Meer JW; Vogels MT; Kullberg BJ
    Biotherapy; 1994; 7(3-4):161-7. PubMed ID: 7865347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards efficient immunotherapy for bacterial infection.
    McCulloch TR; Wells TJ; Souza-Fonseca-Guimaraes F
    Trends Microbiol; 2022 Feb; 30(2):158-169. PubMed ID: 34253452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative and/or integrative therapies for pneumonia under development.
    Cazzola M; Page CP; Matera MG
    Curr Opin Pulm Med; 2004 May; 10(3):204-10. PubMed ID: 15071372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immunity, cytokines, and pulmonary host defense.
    Nelson S; Summer WR
    Infect Dis Clin North Am; 1998 Sep; 12(3):555-67, vii. PubMed ID: 9779378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral and bacterial interactions in pneumonia.
    Wark P
    Expert Rev Respir Med; 2010 Apr; 4(2):221-8. PubMed ID: 20406088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytokines and immunotherapy in infectious diseases].
    van der Meer JW; Netea MG; Kullberg BJ
    Ned Tijdschr Geneeskd; 1999 Nov; 143(45):2252-5. PubMed ID: 10578424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial pneumonia in the elderly: a reappraisal of conventional therapy, with a note on cefamandole.
    Gleckman RA; Esposito AL
    J Am Geriatr Soc; 1979 Aug; 27(8):345-7. PubMed ID: 458085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection.
    Lou W; Venkataraman S; Zhong G; Ding B; Tan JPK; Xu L; Fan W; Yang YY
    Acta Biomater; 2018 Sep; 78():78-88. PubMed ID: 30031912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia.
    Brito V; Niederman MS
    Curr Opin Infect Dis; 2009 Jun; 22(3):316-25. PubMed ID: 19352176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad- versus Narrow-Spectrum Oral Antibiotic Transition and Outcomes in Health Care-associated Pneumonia.
    Buckel WR; Stenehjem E; Sorensen J; Dean N; Webb B
    Ann Am Thorac Soc; 2017 Feb; 14(2):200-205. PubMed ID: 27690519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of ventilator-associated pneumonia caused by multiresistant bacteria.
    Diaz E; Muñoz E; Agbaht K; Rello J
    Curr Opin Crit Care; 2007 Feb; 13(1):45-50. PubMed ID: 17198048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic resistance in community-acquired pneumonia.
    Woodhead M
    Br J Hosp Med; 1992 May 6-19; 47(9):684-7. PubMed ID: 1617342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.